SCHEMBL29348367

SCHEMBL29348367

CN(C)CCOc1ccc(-c2cccc(C3CCC(=O)NC3=O)c2Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 6/20 0.47
DDB1 Q16531 5/20 0.43
ESR1 P03372 4/20 0.40
ESR2 Q92731 3/20 0.40
TNKS O95271 2/20 0.39
POLB P06746 2/20 0.38
PDCD1LG2 Q9BQ51 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
DRD2 P14416 1/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
LRRK2 Q5S007 1/20 0.37
HTR7 P34969 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348358 0.87 CRBN (0.50) CRBNDDB1POLBPDCD1LG2CD274
SCHEMBL29348350 0.87 CRBN (0.49) CRBNDDB1POLBPDCD1LG2CD274
SCHEMBL29348339 0.83 CRBN (0.44) CRBNDDB1ESR1PDCD1LG2CD274
SCHEMBL29348368 0.83 TNF (0.49) CRBNDDB1ESR1ESR2DRD2
SCHEMBL29348356 0.81 CRBN (0.44) CRBNDDB1PDCD1LG2CD274
SCHEMBL29348338 0.80 PDE10A (0.48) CRBNDDB1
SCHEMBL29348431 0.80 CRBN (0.40) CRBNDDB1POLBPDCD1LG2CD274
SCHEMBL29348577 0.80 CRBN (0.44) CRBNDDB1POLBPDCD1LG2CD274
SCHEMBL31068149 0.79 CRBN (0.46) CRBNDDB1PDCD1LG2CD274
SCHEMBL31068109 0.79 CRBN (0.46) CRBNDDB1PDCD1LG2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed